Correction: Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2 Authors: Yifan Xing, Ting Niu, Wenjuan Wang, Jinqing Li, Siying Li, Joseph S. Janicki, Stacey Ruiz, Colin J. Meyer, Xing Li Wang, Dongqi Tang, Yuxia Zhao, Taixing Cui Published: 2024 In Table 1, the Echochardiographic values of LVIDs should not have been a duplicate of what is in LVIDd to both Sham and TAC groups. Please see the correct Table 1 here. Please see the correct Table 1 here. 10.1371/journal.pone.0314793.t001Table 1Echocardiography and pathology of mice treated with and without dh404 for 4 wks after TAC.Dh404 (mg/kg/d)051020 Sham Echocardiography (n)10474IVSd (mm)0.77 ± 0.040.74 ± 0.050.84 ± 0.050.83 ± 0.03LVIDd (mm)4.06 ± 0. 134.14 ± 0.133.96 ± 0.223.93 ± 0.23LVIDs (mm)3.18 ± 0.153.21 ± 0.213.04 ± 0.243.17 ± 0.21LVPWd (mm)0.69 ± 0.030.64 ± 0.020.68 ± 0.020.65 ± 0.05FS (%)21.81 ± 1.7822.53 ± 3.2024.03 ± 2.0119.35 ± 2.00Pathology (n)8463BW (g)25.43 ± 0.7926.05 ± 1.4625.53 ± 1.1025.03 ± 0.50HW/Tibia-L (g/cm)7.52 ± 0.297.61 ± 0.537.40 ± 0.347.02 ± 0.17LW/Tibia-L (g/cm)10.61 ± 0.2910.21 ± 0.8411.03 ± 0.238.96 ± 0.82 TAC Echocardiography (n)165138IVSd (mm)1.14 ± 0.04a0.91 ± 0.06a,b0.99 ± 0.03a,b0.94 ± 0.05a,bLVIDd (mm)5.11 ± 0.14a4.73 ± 0.17a,b4.73 ± 0.11a,b4.71 ± 0.17a,bLVIDs (mm)4.76 ± 0.16a3.36 ± 0.22a,b4.25 ± 0.12a,b4.01 ± 0.18a,bLVPWd (mm)1.08 ± 0.04a0.92 ± 0.06a,b0.90 ± 0.03a,b0.90 ± 0.08a,bFS (%)7.02 ± 1.10a7.88 ± 1.40a,b10.42 ± 0.94a,b,c14.77 ± 1.97a,b,c,dPathology (n)165138BW (g)22.85 ± 0.73a23.56 ± 0.80a22.34 ± 0.67a20.65 ± 0.97aHW/Tibia-L (g/cm)15.54 ± 0.48a12.23 ± 0.65a,b11.68 ± 0.42a,b11.56 ± 0.37a,bLW/Tibia-L (g/cm)26.55 ± 2.23a15.79 ± 4.30a,b17.23 ± 1.21a,b21.17 ± 2.76a,bTwo dimensional echocardiography-guided M-mode echocardiography and pathology were performed 4 weeks after the initiation of TAC or sham surgery in C57BL/6J mice treated with vehicle or dh404 as indicated.Abbreviations: IVSd, interventricular septal thickness at end-diastole; LVIDd, left ventricular internal dimension at end-diastole; LVIDs, left ventricular internal dimension at end-diastole; LVPWd, left ventricular posterior wall thickness at end-diastole; FS, fractional shortening; BW, body weight; HW/Tibia L, heart weight/tibia length ratio; LW/Tibia-L, lung weight/tibia length ratio.ap<0.05 vs sham (0);bp<0.05 vs TAC (0);cp<0.05 vs TAC + dh404 (5 mg/kg/d);dp<0.05 vs TAC + dh404 (10 mg/kg/d) Echocardiography and pathology of mice treated with and without dh404 for 4 wks after TAC. Two dimensional echocardiography-guided M-mode echocardiography and pathology were performed 4 weeks after the initiation of TAC or sham surgery in C57BL/6J mice treated with vehicle or dh404 as indicated. Abbreviations: IVSd, interventricular septal thickness at end-diastole; LVIDd, left ventricular internal dimension at end-diastole; LVIDs, left ventricular internal dimension at end-diastole; LVPWd, left ventricular posterior wall thickness at end-diastole; FS, fractional shortening; BW, body weight; HW/Tibia L, heart weight/tibia length ratio; LW/Tibia-L, lung weight/tibia length ratio. ap<0.05 vs sham (0); bp<0.05 vs TAC (0); cp<0.05 vs TAC + dh404 (5 mg/kg/d); dp<0.05 vs TAC + dh404 (10 mg/kg/d)